These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 9029721)

  • 1. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease.
    Seckl JR
    Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension.
    Seckl JR; Benediktsson R; Lindsay RS; Brown RW
    J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):447-55. PubMed ID: 8547169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
    Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
    Steroids; 1996 Apr; 61(4):263-9. PubMed ID: 8733012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR; Cleasby M; Nyirenda MJ
    Kidney Int; 2000 Apr; 57(4):1412-7. PubMed ID: 10760076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone.
    Lindsay RS; Lindsay RM; Waddell BJ; Seckl JR
    Diabetologia; 1996 Nov; 39(11):1299-305. PubMed ID: 8932995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.
    McTernan CL; Draper N; Nicholson H; Chalder SM; Driver P; Hewison M; Kilby MD; Stewart PM
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4979-83. PubMed ID: 11600574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring.
    Sugden MC; Langdown ML; Munns MJ; Holness MJ
    Eur J Endocrinol; 2001 Oct; 145(4):529-39. PubMed ID: 11581014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring.
    Welberg LA; Seckl JR; Holmes MC
    Eur J Neurosci; 2000 Mar; 12(3):1047-54. PubMed ID: 10762336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring.
    Nyirenda MJ; Lindsay RS; Kenyon CJ; Burchell A; Seckl JR
    J Clin Invest; 1998 May; 101(10):2174-81. PubMed ID: 9593773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
    Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms.
    Seckl JR
    Mol Cell Endocrinol; 2001 Dec; 185(1-2):61-71. PubMed ID: 11738795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring.
    Lindsay RS; Lindsay RM; Edwards CR; Seckl JR
    Hypertension; 1996 Jun; 27(6):1200-4. PubMed ID: 8641724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC; Seckl JR; Holmes MC; Wyrwoll CS
    Acta Physiol (Oxf); 2014 Feb; 210(2):288-95. PubMed ID: 24330050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development.
    Yu P; Zhou J; Ge C; Fang M; Zhang Y; Wang H
    Sci Total Environ; 2022 Jun; 827():154396. PubMed ID: 35259391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Wood PJ; Nuutila M; Andersson S
    J Clin Endocrinol Metab; 2003 Jan; 88(1):493-500. PubMed ID: 12519895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure (Review).
    Nyirenda MJ; Seckl JR
    Int J Mol Med; 1998 Nov; 2(5):607-14. PubMed ID: 9858661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cold exposure on the levels of glucocorticoids, 11-hydroxysteroid dehydrogenase 2, and placental vascularization in a rat model.
    Zhang QJ; Chen SW; Xu X; Zhang HL; Yan JY
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):11961-11974. PubMed ID: 38164859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal glucocorticoids and long-term programming.
    Seckl JR
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U49-62. PubMed ID: 15554887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2.
    Brown RW; Chapman KE; Kotelevtsev Y; Yau JL; Lindsay RS; Brett L; Leckie C; Murad P; Lyons V; Mullins JJ; Edwards CR; Seckl JR
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):1007-17. PubMed ID: 8611140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.